Recent ACAD Stock Price | ACAD Stock Predictions | |
$16.31 | +80.44% |
$29.43 |
Recent ACAD Analyst Ratings Breakdown, Making ACAD Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 12 | 12 | 13 | 12 |
Buy ratings: | 2 | 2 | 2 | 2 |
Hold ratings: | 5 | 6 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 1 | 1 | 1 | 1 |
Average rating: | 1.8 | 1.86 | 1.76 | 1.8 |
For the ACAD stock predictions from the analysts covering Acadia Pharmaceuticals Inc, we have collected all of the individual ACAD stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 19 different analysts covering ACAD (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ACAD stock predictions may vary widely, another useful metric to consider is the median ACAD stock prediction, which represents the price at which half of the analysts
made ACAD stock predictions that were higher and half made ACAD stock predictions that were lower. This makes for a different take on the ACAD stock predictions out there, as compared to average or mean.
And that median across all the individual ACAD stock predictions was: $30.0 as of 2024-04-26.
The very highest of the ACAD stock predictions for one year price target was $39.0, while the very lowest of the ACAD stock predictions in the analyst group was
$13.0 (with a standard deviation of $6.31). Get the latest Zacks research report on ACAD — FREE
Find out: ACAD next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ORI Stock Predictions
OMCL Stock Predictions
TA Stock Predictions
FTV Stock Predictions
OGS Stock Predictions
XP Stock Predictions
GTHX Stock Predictions
RM Stock Predictions
ATNX Stock Predictions
|
|
Buy (3.20 out of 4) 45th percentile
(ranked lower than approx. 55% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |